Robert C Jackson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Robert C Jackson

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Plos Computational Biology|May 4, 2017

Modelling of the cancer cell cycle as a tool for rational drug development: A systems pharmacology approach to cyclotherapyRobert C Jackson, Giovanni Y Di Veroli, Siang-Boon Koh, et al.

Radiation and Environmental Biophysics|December 17, 2013

Sex differences in the incidence of chronic myeloid leukemiaTomas Radivoyevitch, Gradimir M Jankovic, Ramon V Tiu, et al.

Journal of Medicinal Chemistry|May 14, 2010

Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitorsShudong Wang, Carol A Midgley, Frederic Scaërou, et al.

Chemistry & Biology|November 2, 2010

Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agentsShudong Wang, Gary Griffiths, Carol A Midgley, et al.

Cancer Research|November 29, 2013

Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imagingMichael D Allen, Phuong Luong, Chantelle Hudson, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Plos Computational Biology|May 4, 2017

Modelling of the cancer cell cycle as a tool for rational drug development: A systems pharmacology approach to cyclotherapyRobert C Jackson, Giovanni Y Di Veroli, Siang-Boon Koh, et al.

Radiation and Environmental Biophysics|December 17, 2013

Sex differences in the incidence of chronic myeloid leukemiaTomas Radivoyevitch, Gradimir M Jankovic, Ramon V Tiu, et al.

Journal of Medicinal Chemistry|May 14, 2010

Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitorsShudong Wang, Carol A Midgley, Frederic Scaërou, et al.

Chemistry & Biology|November 2, 2010

Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agentsShudong Wang, Gary Griffiths, Carol A Midgley, et al.

Cancer Research|November 29, 2013

Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imagingMichael D Allen, Phuong Luong, Chantelle Hudson, et al.

Pageof 2